JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM) - Cash Flow Conversion Efficiency
Based on the latest financial reports, JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM) has a cash flow conversion efficiency ratio of 0.095x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs3.62 Billion ≈ $39.19 Million USD) by net assets (Rs38.06 Billion ≈ $411.58 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See JBCHEPHARM defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
JB Chemicals & Pharmaceuticals Limited - Cash Flow Conversion Efficiency Trend (2006–2026)
This chart illustrates how JB Chemicals & Pharmaceuticals Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.
JB Chemicals & Pharmaceuticals Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of JB Chemicals & Pharmaceuticals Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Cleanaway Waste Management Ltd
AU:CWY
|
0.060x |
|
Shanghai Phichem Material Co Ltd Class A
SHE:300398
|
0.030x |
|
Changchun High & New Technology Industries Group Inc
SHE:000661
|
-0.020x |
|
Graham Holdings Co
NYSE:GHC
|
0.014x |
|
Sam Chun Dang Pharm. Co. Ltd
KQ:000250
|
-0.043x |
|
PT Alamtri Resources Indonesia Tbk
JK:ADRO
|
0.051x |
|
ShenZhen Special Economic Zone Real Estate & Properties Group Co Ltd
SHE:000029
|
-0.001x |
|
Constellium SE
F:3OK
|
0.064x |
Annual Cash Flow Conversion Efficiency for JB Chemicals & Pharmaceuticals Limited (2006–2026)
The table below shows the annual cash flow conversion efficiency of JB Chemicals & Pharmaceuticals Limited from 2006 to 2026. For the full company profile with market capitalisation and key ratios, see market value of JB Chemicals & Pharmaceuticals Limited.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-03-31 | Rs41.59 Billion ≈ $449.80 Million |
Rs7.11 Billion ≈ $76.85 Million |
0.171x | -35.00% |
| 2025-03-31 | Rs34.33 Billion ≈ $371.30 Million |
Rs9.02 Billion ≈ $97.60 Million |
0.263x | -4.02% |
| 2024-03-31 | Rs29.23 Billion ≈ $316.15 Million |
Rs8.01 Billion ≈ $86.58 Million |
0.274x | +8.58% |
| 2023-03-31 | Rs24.80 Billion ≈ $268.24 Million |
Rs6.26 Billion ≈ $67.66 Million |
0.252x | +217.05% |
| 2022-03-31 | Rs21.39 Billion ≈ $231.28 Million |
Rs1.70 Billion ≈ $18.40 Million |
0.080x | -54.17% |
| 2021-03-31 | Rs18.13 Billion ≈ $196.12 Million |
Rs3.15 Billion ≈ $34.04 Million |
0.174x | -9.35% |
| 2020-03-31 | Rs14.38 Billion ≈ $155.51 Million |
Rs2.75 Billion ≈ $29.78 Million |
0.191x | +47.08% |
| 2019-03-31 | Rs14.83 Billion ≈ $160.37 Million |
Rs1.93 Billion ≈ $20.88 Million |
0.130x | +52.83% |
| 2018-03-31 | Rs14.44 Billion ≈ $156.20 Million |
Rs1.23 Billion ≈ $13.31 Million |
0.085x | -41.88% |
| 2017-03-31 | Rs13.66 Billion ≈ $147.71 Million |
Rs2.00 Billion ≈ $21.65 Million |
0.147x | +14.95% |
| 2016-03-31 | Rs10.95 Billion ≈ $118.46 Million |
Rs1.40 Billion ≈ $15.10 Million |
0.128x | +0.15% |
| 2015-03-31 | Rs9.95 Billion ≈ $107.59 Million |
Rs1.27 Billion ≈ $13.70 Million |
0.127x | +1049.86% |
| 2014-03-31 | Rs10.43 Billion ≈ $112.78 Million |
Rs-139.78 Million ≈ $-1.51 Million |
-0.013x | -116.10% |
| 2013-03-31 | Rs10.20 Billion ≈ $110.34 Million |
Rs849.32 Million ≈ $9.19 Million |
0.083x | -90.82% |
| 2012-03-31 | Rs9.70 Billion ≈ $104.90 Million |
Rs8.80 Billion ≈ $95.14 Million |
0.907x | +368.67% |
| 2011-03-31 | Rs6.92 Billion ≈ $74.79 Million |
Rs1.34 Billion ≈ $14.47 Million |
0.194x | -9.87% |
| 2010-03-31 | Rs5.68 Billion ≈ $61.44 Million |
Rs1.22 Billion ≈ $13.19 Million |
0.215x | +10.50% |
| 2009-03-31 | Rs4.69 Billion ≈ $50.71 Million |
Rs911.05 Million ≈ $9.85 Million |
0.194x | +210.91% |
| 2008-03-31 | Rs4.53 Billion ≈ $48.99 Million |
Rs283.11 Million ≈ $3.06 Million |
0.062x | +17.36% |
| 2007-03-31 | Rs4.18 Billion ≈ $45.26 Million |
Rs222.82 Million ≈ $2.41 Million |
0.053x | -21.99% |
| 2006-03-31 | Rs3.30 Billion ≈ $35.73 Million |
Rs225.51 Million ≈ $2.44 Million |
0.068x | -- |
About JB Chemicals & Pharmaceuticals Limited
J. B. Chemicals & Pharmaceuticals Limited manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally. The company's API product portfolio includes diclofenac sodium, diethylamine, acid, and potassium; and nifedipine, atenolol, and cilnidipine; and ciprofloxacin, cetirizine, and meclizine HCI. It also provides dos… Read more